Kurt Jacobus, Ph.D.President & Chief Executive Officer
Dr. Jacobus has served as the President & CEO of MedShape since 2006. Prior to that, he spent five years as a management consultant with McKinsey & Company, focusing on the development of growth businesses from start-up to Fortune 500 clients. He has over 10 years of early stage company experience, leading or supporting the start of over a dozen new businesses. Dr. Jacobus received a Ph.D. in mechanical engineering from the University of Illinois. Based on his graduate work at the University of Illinois, he brings a strong background in shape memory materials. Dr. Jacobus sits on the Advisory Board for the Georgia Tech School of Materials Science and Engineering, the Advisory Board for Georgia Tech’s Center for Advanced Bioengineering for Soldier Survivability and the Metropolitan Atlanta Chamber of Commerce’s Bioscience Industry Leadership Council.
BOARD OF DIRECTORS
Niles NoblittChairman of the Board
Mr. Noblitt is retired Chairman of the Board of Directors of Biomet, Inc., Warsaw, Indiana. He was a co-founder of the Company, and Board member from 1977 until retirement in 2007. Mr. Noblitt also serves as Board Member to NICO Corporation, and GoNow Technologies LLC and served as a Board member of OrthoHelix prior to its acquisition by Tornier. Mr. Noblitt received a BS degree in Biological Engineering at Rose-Hulman Institute of Technology, Terre Haute, Indiana and now serves as its Vice Chairman of the Board of Trustees. Mr. Noblitt has served as an Observer to MedShape’s Board of Directors from 2010 and as a Director since 2012.
Gregory S. Dane
Mr. Dane is currently a consultant to the Georgia Research Alliance on matters related to economic development, assisting in the translation of high-impact life science research programs across Georgia’s research institutions. Previously, he was Director of Innovation in the Department of Biomedical Engineering at the Georgia Institute of Technology and Emory University where he was instrumental in commercializing numerous university-based medical technologies through licensing and startup creation. Prior to this role, Mr. Dane served for ten years as President and Chief Executive Officer of three development-stage bioscience companies, and fifteen years in various senior management positions with Baxter Healthcare Corporation. He has served on numerous Boards of Directors, and has been an advisor in Atlanta to the Center for Innovative Cardiovascular Technologies, the Pediatric Cardiovascular Consortium, the Translational Research Institute for Biomedical Engineering and Science, and the Global Center for Medical Innovation. Mr. Dane has served as a Director of MedShape since 2007.
Kenneth A. Gall, Ph.D.
Dr. Gall is Professor and Chairman of Mechanical Engineering and Materials Science at Duke University. He has over 225 publications that have been cited over 14,000 times. Over the past 20 years he has given over 300 presentations at conferences, companies, and universities. In addition to his research and teaching, he has consulted for various public and private companies, the US Military and the US Intelligence Community. He has also served as an expert witness in a numerous patent and product litigations involving materials across several industries. Finally, he is a passionate entrepreneur who has several dozen patents and has founded or served on the board of seven medical device start-up companies. Dr. Gall has served as a Director of MedShape since the founding of the company.
Paul F. HillsChairman, Hills Capital Management
Mr. Hills is currently Chairman of Hills Capital Management, an investment company focused on managing public and private investments. Prior to his position at Hills Capital Management, Mr. Hills spent 35 years as an Executive and co-founder of Sage Products, Inc., a medical device marketing and manufacturing company located in Cary, Illinois. Since its inception in 1971, Sage Products has developed an international reputation as an innovator of products that provide superior patient care. In addition to his board position with MedShape, Inc., Mr. Hills and his wife Barbara serve as Trustees of the Naples Winter Wine Festival and as Chairs of Advocate Good Shepherd Hospital’s capital campaign for facilities modernization.
Thomas E. HillsPresident and Chief Investment Officer, Hills Capital Management
Mr. Hills is currently Chief Investment Officer and Co-Founder of Hills Capital Management, the vehicle which manages investments for the Hills family in Barrington, IL. Hills Capital was an early equity investor in MedShape. In addition to his experience in the asset management business, Mr. Hills was in sales and marketing at Sage Products, Inc., a medical device marketing and manufacturing company located in Cary, Illinois. Mr. Hills holds a BBA from St. Norbert College and an MBA from Loyola University of Chicago.
Douglas W. Kohrs
Mr. Kohrs is currently the President of FFEN (Foundation for Essential Needs), and separately serves as a Strategy Consultant to the Medical Device Industry. Mr. Kohrs served as the President, Chief Executive Officer and a Director of Tornier N.V., a publicly held medical device company from July 2006 to November 2012. Prior to joining Tornier, he served as President and Chief Executive Officer of American Medical Systems Holdings, Inc., a publicly held medical device company, from April 1999 until January 2005 and then served as Chairman of the Board until May 2006. Prior to that, Mr. Kohrs was General Manager of Sulzer Spine-Tech Inc., an orthopaedic implant manufacturer of which he was a founding member beginning in August 1991. Mr. Kohrs has served on the Board of Directors of ev3 Inc. and Kyphon, Inc., both publicly held medical device companies. Mr. Kohrs received a BA degree from Austin College and an MBA from Northeastern University. Mr. Kohrs has served as a Director of MedShape since November 2014.
Dennis D. Stripe
Mr. Dennis Stripe has almost 40 years of medical device experience from various positions in management, sales and marketing on a global basis at Kendall Healthcare Products, Smith & Nephew, and Stryker Corporation. Most recently In 2008, Mr. Stripe joined OrthoHelix Surgical Designs, a medical technology company focusing on implants and instruments for reconstruction surgery. Mr. Stripe remained at OrthoHelix Surgical Designs until 2013 and served as Chief Executive Officer and as member of the Board of Directors for five years. OrthoHelix Surgical Designs was ultimately sold to Nasdaq listed company Tornier N.V., a transaction led by Mr. Stripe. He also serves as Chairman of the Board of Episurf Medical AB, a public company based in Stockholm, Board member of Central Mutual Insurance Companies, in Ohio, and an advisor for Compliant Innovations, Inc. in the Silicon Valley. Mr. Stripe holds a Bachelor’s Degree in Business from Ohio Northern University.